Author

A. Mading

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

B. Wang· 1 shared F. Wu· 1 shared H. Chen· 1 shared H. Liu· 1 shared M. Wang· 1 shared Q. Chen· 1 shared R. Guo· 1 shared S. Li· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Wang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CRISPR/Cas9 screens Reveal Dasatinib Targets of Inhibiting T cell Activation and Proliferation

M. Wang, Q. Chen, H. Liu, H. Chen, B. Wang, W. Zhang, A. Mading, W. Li, S. Li, H. Liu, Z. Gu, S. Liu, R. Guo, W. Li, T. Xiao, F. Wu

This study identifies dasatinib targets in T cell activation and proliferation using CRISPR/Cas9 screening in Jurkat cells, revealing both known and novel targets and their functional roles.

bioRxiv · Oct 21, 2018 · PreprintCancer Biology